FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023​

2024-03-19T15:33:27+00:00Advanced Manufacturing, Agriculture, Auto parts and accessories, Automotive Aftermarket, Automotive Dealers, Behavioral Health, Biotech, Blogs, Car Washes, Cardiology, Cloud Services, Collision, Construction, Consumer, Dermatology, Distribution, Downloads, E-commerce, E-Learning, Education & Human Capital Development News, Electronics, Engineering, ENT & Allergy, Entertainment, Environmental Services, Federal Contracting, Financial Services, FOCUS Sale Preparation, Food & Beverage, Gastroenterology, Government and Defense, Healthcare, Home Health & Hospice, Human Capital Management, Industrials and Energy, Managed Service Providers, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures, Oil and Lube, Paint Jobbers, Supply Chain, Technology Services, Telecom Technologies & Services, Tire and Service|

Washington, DC, (July 27, 2023) – FOCUS Investment Banking (“FOCUS”) ...

FOCUS Investment Banking Represents Clinart in its Acquisition by Greater Cincinnati-based CTI Clinical Trial and Consulting Services

2024-02-12T23:33:19+00:00Healthcare, Life Sciences, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures|

FOCUS Investment Banking (“FOCUS”), a Washington DC-based investment bank, represented Clinart, a regional CRO (Contract Research Organization) located in Dubai, in its acquisition by CTI, Clinical Trial and Consulting Services, an international CRO headquartered in Cincinnati, Ohio.

Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010

2024-02-12T23:34:11+00:00Biotech, Healthcare, International News, International Transactions, Life Sciences, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures|

Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.

Go to Top